Zydus Expands Its MedTech Arsenal
Best known for its work in interventional cardiology, Zydus has made a name for itself producing life-saving medical devices such as catheters, balloons, and stents—vital tools in treating heart conditions. This acquisition marks a natural evolution, broadening its footprint into orthopedic prostheses, a fast-growing sector as global demand for joint replacement surges.
“In Amplitude Surgical, we see several medium-term and long-term growth opportunities with respect to portfolio, capabilities, manufacturing, and geographies,” said Sharvil Patel, Zydus’ Managing Director, hinting at a broader strategy to integrate and scale up the new business.
Amplitude Surgical, a leading player in knee and hip prostheses, has been riding a wave of success, reporting €106 million in sales for the fiscal year ending June 30, 2024.
Regulatory Green Light Expected by Mid-2024
The acquisition is expected to be finalized by June 2024, pending regulatory approvals from France’s Autorité des Marchés Financiers (AMF).
French law firm Darrois Villey Maillot Brochier is advising Zydus on legal matters, while Willkie Farr & Gallagher LLP is representing PAI Partners.
On the financial front, BNP Paribas is exclusively advising Zydus, while Rothschild & Co. is working with PAI Partners.
